Newsletter | September 25, 2026

09.25.26 -- Shaping Drug Development By Starting With The Disease With Roche's Sylke Poehling, Ph.D.

SPONSOR

 

The New Economics of Biologics: Breaking the $50/g Barrier — Now

What do different processing scenarios mean for mAb manufacturing economics? In this new report, cost modeling shows that intensified single-use and continuous processes can reduce costs across demand levels, while stainless-steel facilities become cost-competitive only at higher titers and larger campaign sizes. Read the report to explore the economics of breaking the $50/g barrier.

Improved Clearance Of Host Cell Proteins After Virus Inactivation

Webinar | Cytiva

Learn how post-viral inactivation filtration can support precipitate and host cell protein removal while balancing throughput.

 

Efficient-Pro Medium And Feed Marketing

Video | Thermo Fisher Scientific

Gain insight into how this advanced medium and feed system supports efficient, consistent cell culture performance.

 

The Journey To Safety Through Viral Clearance

Video | MilliporeSigma

Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines, as well as how to free your teams and trust your project.

Immunogenicity — Challenge For Protein Drugs

Webinar | ATUM

This presentation discusses the shift in pharmaceuticals from small-molecule drugs to protein biologics and the associated challenges, particularly the immunogenic response.

Shaping Drug Development By Starting With The Disease With Roche's Sylke Poehling, Ph.D.

Video | Cell & Gene

In episode 137 of Cell & Gene: The Podcast, Host Erin Harris talks with Sylke Poehling, Ph.D., SVP and Global Head: Therapeutic Modalities, pRED; Roche Gene Therapy Center of Excellence about how the company selects the optimal modality by starting with disease biology.

Building Robust Potency Assays

Webinar | LICORbio

Robust potency assays depend on reliable biological readouts. Find out how quantitative protein expression analysis can provide sensitive, reproducible measurements of cellular responses.

SPONSOR

 

Webinar: Determining Antibody-Drug Conjugate Positional Isomer Distribution with Nonreduced CE-SDS and HIC

Antibody-drug conjugate characterization requires more than measuring drug-to-antibody ratio. Discover how combining HIC and nonreduced CE-SDS can reveal both DAR and payload location, enabling positional isomer analysis without additional techniques. This webinar explores practical method considerations, data integration, and automated workflows using Agilent systems to help streamline ADC characterization and generate deeper structural insights. Click here to learn more.

Connect With Bioprocess Online: